The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing gene therapies for cardiovascular dise

Total Raised

$11 M

Rounds

1

Links

Verticals

Biotechnology
Health Care
Life Science

Investment History

  1. Series A

    Aug 2019

    $11M

Team

Magdalene Cook

President and CEO

Arthur Feldman

Chief Scientific Advisor, Renovacor, Inc., Laura H. Carnell Professor of Medicine, cardiology

Fred Driscoll

CFO

Kumar Dhanasekharan

Senior Vice President, Technical Operations